611 results on '"Fauser, Bart C. J. M."'
Search Results
2. Assisted reproductive technology
3. Future perspectives part III
4. Future perspectives part IV
5. Incidental findings on coronary computed tomography in women with selected reproductive disorders
6. Pregnancy Complications and Children Outcomes in Patients with Polycystic Ovarian Syndrome
7. Ovulation Induction for Anovulatory Patients
8. Assisted reproductive technology
9. Life course approach in obstetrics and gynaecology for patient care, education and research
10. PCOS: Implications of Cardiometabolic Dysfunction
11. Complications of Pregnancy
12. Declining global fertility rates and the implications for family planning and family building: an IFFS consensus document based on a narrative review of the literature.
13. Trabecular bone density in middle-aged women with reproductive disorders
14. Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome
15. Cardiovascular and Metabolic Health of 74 Children From Women Previously Diagnosed With Polycystic Ovary Syndrome in Comparison With a Population-Based Reference Cohort
16. Aligning Bayesian Network Classifiers with Medical Contexts
17. The case for mild stimulation for IVF: recommendations from The International Society for Mild Approaches in Assisted Reproduction
18. PCOS: Implications of Cardiometabolic Dysfunction
19. Polycystic Ovary Syndrome : Definitions and Epidemiology
20. The Insulin-Like Growth Factor (IGF) System in Human Ovary and Its Relevance to Polycystic Ovarian Syndrome
21. THERAPY: Unexplained infertility —ongoing transatlantic debate
22. Dynamics of Human Follicle Development
23. Insulin action in women with polycystic ovary syndrome and its relation to gestational diabetes
24. Intraovarian Control of Early Folliculogenesis
25. REPRODUCTIVE ENDOCRINOLOGY: Revisiting ovulation induction in PCOS
26. Sex Steroid Hormones and Reproductive Disorders: Impact on Women’s Health
27. Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome
28. The Impact of Ovarian Stimulation With Recombinant FSH in Combination With GnRH Antagonist on the Endometrial Transcriptome in the Window of Implantation
29. Heterozygosity for the Classical Galactosemia Mutation Does Not Affect Ovarian Reserve and Menopausal Age
30. Who will conceive with IVF?
31. The cardiovascular risk profile of middle-aged women with polycystic ovary syndrome
32. The cardiovascular risk profile of middle-aged women with polycystic ovary syndrome
33. Chief Editor's 2019 annual report
34. Drug-free in-vitro activation of ovarian cortex; can it really activate the 'ovarian gold reserve'?
35. Next steps toward AMH as a robust biomarker for assessing ovarian aging in individual women
36. Cardiometabolic health in offspring of women with PCOS compared to healthy controls: a systematic review and individual participant data meta-analysis
37. Contemporary Pharmacological Manipulation in Assisted Reproduction
38. Prognostic testing for ovarian reserve
39. Indications for IVF treatment: From diagnosis to prognosis
40. Renaming PCOS—A Two-State Solution
41. Variants in SULT2A1 Affect the DHEA Sulphate to DHEA Ratio in Patients With Polycystic Ovary Syndrome But Not the Hyperandrogenic Phenotype
42. Pregnancy and Birth After GnRH Agonist Treatment for Induction of Final Oocyte Maturation in a Woman Undergoing Ovarian Stimulation for ICSI, Using a GnRH Antagonist (Orgalutran/Antagon) to Prevent a Premature LH Surge: A Case Report
43. Aligning Bayesian Network Classifiers with Medical Contexts
44. Retrieval, Maturation, and Fertilization of Immature Oocytes Obtained from Unstimulated Patients with Polycystic Ovary Syndrome
45. Uncertainty Remains in Women with PCOS Regarding the Increased Incidence of Cardiovascular Disease Later in Life, Despite the Indisputable Presence of Multiple Cardiovascular Risk Factors at a Young Age
46. Follicular Phase Endocrine Characteristics during Ovarian Stimulation and GnRH Antagonist Cotreatment for IVF: RCT Comparing recFSH Initiated on Cycle Day 2 or 5
47. Limited Value of Ovarian Function Markers following Orthotopic Transplantation of Ovarian Tissue after Gonadotoxic Treatment
48. Genes Involved in Initial Follicle Recruitment May Be Associated with Age at Menopause
49. Does an association exist between menstrual cycle length within the normal range and ovarian reserve biomarkers during the reproductive years? A systematic review and meta-analysis
50. Next Steps Toward AMH as a Robust Biomarker for Assessing Ovarian Aging in Individual Women
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.